Portuguese Registry on Interventional Cardiology

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01867801

Acronym

PRIC

Enrollment

50000

Registered

2013-06-04

Start date

2002-01-31

Completion date

2018-12-31

Last updated

2017-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

PCI, Coronary disease, Ischemia

Brief summary

The purpose of this Registry is creating a database management that allows continuous monitoring characteristics, evolution, prognostic indicators and management of patients undergoing coronary angioplasty in Portuguese Hospitals, and identify the appropriateness of clinical and interventional practice recommendations for diagnosis and treatment of coronary disease and monitoring its evolution.

Detailed description

Cardiovascular disease remains the main cause of death in Portugal and approximately one quarter of these are directly to ischemic heart disease. In order to better characterize percutaneous coronary intervention in Portugal, the Portuguese Society of Cardiology has promoted the Portuguese registry on percutaneous coronary intervention. This will include all adult patients (≥ 18 years), eligible for percutaneous coronary intervention (PCI) in accordance with PCI state-of-art recommendations (including unstable and stable coronary disease). The Cardiology department where the patient has been hospitalized is responsible for the patient inclusion in the study. Excluded patients are those in whom the preferred treatment is Coronary Artery Bypass Graft (CABG), age under 18 years or life expectancy of less than 12 months.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

1. Patients with: * stable angina or, * stabilized angina pectoris or, * atypical chest pain or, * no chest pain but with documented silent ischemia 2. At least one stenosis is present of at least 50% in one major native epicardial coronary artery and supplying viable myocardium 3. Eligible for PCI 4. Informed consent

Exclusion criteria

1. Patients in whom the preferred treatment is CABG; 2. Contra-indication to dual antiplatelet therapy 3. Coronary artery disease precluding PCI 4. A life expectancy of less than 1 year 5. Age under 21

Design outcomes

Primary

Measure	Time frame
Major adverse cardiac event rate (MACE) MACE: A composite of all cause death, documented Myocardial Infarction (MI), unplanned hospitalization leading to urgent revascularization.	24 months

Secondary

Measure	Time frame	Description
Total mortality	12 month	Total mortality at 12 month

Countries

Portugal

Contacts

Primary ContactSandra M Corker

sandra.corker@spc.pt00351 239 838 101

Outcome results